H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq falls as Alphabet set for record loss amid AI spending woes
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: CMPX) | Delayed: 0.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.76 | 52 Week High | $ | |||
| Open | $0.78 | 52 Week Low | $ | |||
| Day High | $0.81 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $ | |||
| Volume | 1,006,676 | |||||
